Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Name (Synonyms) | Correlation |
---|
Navigate: Correlations HPO
There is one clinical trial.
To evaluate the effect of the ECOBICI program in Mexico City on health indicators, activity levels, mental health, and quality of life and diet after 3 months of follow-up.
Description: Assessed by questionnaire and expressed in minutes per week
Measure: Physical activity not related to the bicycle sharing program Time: up to 1.5 months.Description: Assessed by questionnaire and expressed in minutes per week
Measure: Physical activity not related to the bicycle sharing program Time: up to 3 months.Description: Assessed by questionnaire and daily monitoring of the users' trips through automatic system records done at bike-stations of the program and by a mobile GPS application. Expressed in kilometers per trip per day and time in minutes per trip per date.
Measure: Physical activity of bicycle sharing program Time: up to 1.5 months.Description: Assessed by questionnaire and daily monitoring of the users' trips through automatic system records done at bike-stations of the program and by a mobile GPS application. Expressed in kilometers per trip per day and time in minutes per trip per date.
Measure: Physical activity of bicycle sharing program Time: up to 3 months.Description: Assessed by direct measurements done by trained staff and expressed in kg/m^2. Classified according to the following criteria: low weight if it´s <18.5 kg/m^2, normal if it goes from 18.5 to 24.9 kg /m^2 , overweight if it goes from 25 to 29.9 kg/m^2 or obese if it´s >30 kg/m^2.
Measure: Changes in body mass index Time: up to 3 months.Description: Assessed by direct measurements done by trained staff and expressed in mmHg. Classified with each participant's result according to the following criteria: normotensive if the systolic blood pressure (SBP) is <140 mmHg and diastolic blood pressure (DBP) <90 mmHg or hypertensive if the SBP is ≥140 mmHg or DBP ≥90 mmHg.
Measure: Changes in blood pressure Time: up to 3 months.Description: Assessed by direct measurements done by trained staff and expressed in cm. Classified as high if > 92 centimeters (cm) for men or > 80 cm for women.
Measure: Changes in waist circumference Time: up to 3 months.Description: Assessed by direct measurements done by trained staff and expressed in cm.
Measure: Changes in hip circumference Time: up to 3 months.Description: Assessed by questionnaire. Expressed by a general score. Depression if ≥9 for adults and ≥5 for older adults.
Measure: Changes in mental health status Time: up to 1.5 months.Description: Assessed by questionnaire. Expressed by a general score. Depression if ≥9 for adults and ≥5 for older adults.
Measure: Changes in mental health status Time: up to 3 months.Description: Assessed by questionnaire. Expressed by a percentage.
Measure: Changes in physical health Time: up to 1.5 months.Description: Assessed by questionnaire. Expressed by a percentage.
Measure: Changes in physical health. Time: up to 3 months.Description: Assessed by questionnaire. Expressed by a percentage.
Measure: Changes in general health status. Time: up to 1.5 months.Description: Assessed by questionnaire. Expressed by a percentage.
Measure: Changes in general health status. Time: up to 3 months.Description: Assessed by questionnaire. Expressed by a percentage. Good and bad
Measure: Changes quality of life Time: up to 3 months.Description: Assessed by a a semi-quantitative food frequency questionnaire. Expressed by a percentage.
Measure: Changes in dietary patterns Time: up to 1.5 months.Description: Assessed by a a semi-quantitative food frequency questionnaire. Expressed by a percentage.
Measure: Changes in dietary patterns Time: up to 3 months.Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports